Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Jun 16, 2022; 14(6): 387-401
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.387
Table 2 Patient characteristics in different phases of the learning curve

Overall
Colon
Rectal
Phase I (1-109)Phase II (110-144)Phase III (145-214)P valuePhase I (1-57)Phase II (58-133)P valuePhase I (1-51)Phase II (52-81)P value
N109357057765130
SexMale68 (62.4%)24 (68.6%)36 (51.4%)NS37 (64.9%)41 (53.9%)NS30 (58.8%)20 (66.7%)NS
Female41 (37.6%)11 (31.4%)34 (48.6%)20 (35.1%)35 (46.1%)21 (41.2%)10 (33.3%)
Age (yr)71.5 (12)70 (13)69.5 (14)NS72 (14)71 (13)NS69.5 (12)67 (16)NS
BMI (kg/m2)27 (5)28 (4)27 (5)NS28 (6)28 (5)NS26 (3)27.5 (6)NS
ASA scoreI36 (33%)13 (37.1%)22 (31.4%)NS14 (24.6%)21 (27.6%)NS21 (41.2%)15 (50%)NS
II62 (56.9%)16 (45.7%)39 (55.7%)35 (61.4%)44 (57.9%)27 (52.9%)11 (36.7%)
III11 (10.1%)6 (17.1%)9 (12.9%)8 (14%)11 (14.5%)3 (5.9%)4 (13.3%)
DiagnosisMalignancy106 (97.2%)34 (97.1%)66 (94.3%)NS54 (94.7%)71 (93.4%)NS51 (100%)30 (100%)-
Diverticulitis2 (1.8%)1 (2.9%)3 (4.3%)2 (3.5%)4 (5.3%)--
Volvulus1 (0.9%)0 (0%)0 (0%)1 (1.8%)0 (0%)--
Crohn’s disease0 (0%)0 (0%)1 (1.4%)0 (0%)1 (1.3%)--
Previous operation13 (11.9%)2 (5.7%)2 (2.9%)NS9 (15.8%)4 (5.3%)0.044 (7.8%)0 (0%)NS
T124 (22.6%)6 (17.6%)21 (31.8%)NS12 (22.6%)21 (29.2%)NS12 (23.5%)6 (20%)NS
234 (32.1%)7 ( (20.6%)22 (33.3%)16 (30.2%)23 (31.9%)18 (35.3%)6 (20%)
343 (40.6%)20 (58.8%)22 (33.3%)21 (39.6%)26 (36.1%)20 (39.2%)18 (60%)
45 (4.7%)1 (2.9%)1 (1.5%)4 (7.5%)2 (2.8%)1 (2%)0 (0%)
N077 (74.5%)25 (73.5%)49 (74.2%)NS36 (67.9%)53 (73.6%)NS41 (80.4%)23 (76.7%)NS
123 (21.7%)6 (17.6%)13 (19.7%)16 (30.2%)14 (19.4%)6 (13.7%)5 (16.7%)
24 (3.8%)3 (8.8%)4 (6.1%)1 (1.9%)5 (6.9%)3 (5.9%)2 (6.7%)
M0106 (100%)34 (100%)65 (98.5%)NS53 (100%)72 (100%)-51 (100%)29 (96.7%)NS
10 (0%)0 (0%)1 (1.5%)--0 (0%)1 (3.3%)
Neoadjuvant modality6 (5.5%)5 (14.3%)8 (11.4%)NS0 (0%)2 (2.6%)NS6 (11.8%)11 (36.7%)0.008
Complexity level150 (54.1%)13 (37.1%)44 (62.9%)NS29 (50.9%)45 (59.2%)NS30 (58.8%)12 (40%)NS
242 (38.5%)20 (57.1%)20 (28.6%)21 (36.8%)23 (30.3%)20 (39.2%)18 (60%)
32 (1.8%)1 (2.9%)3 (4.3%)2 (3.5%)4 (5.3%)0 (0%)0 (0%)
46 (5.5%)1 (2.9%)3 (4.3%)5 (8.8%)4 (5.3%)1 (2%)0 (0%)
OperationRight colectomy34 (31.2%)13 (37.1%)29 (41.4%)NS34 (59.6%)42 (55.3%)NS--NS
Left colectomy10 (9.2%)6 (17.1%)15 (21.4%)10 (17.5%)21 (27.6%)--
Sigmoidectomy13 (11.9%)2 (5.7%)11 (15.7%)13 (22.8%)13 (17.1%)--
Low anterior resection46 (42.2%)13 (37.1%)13 (18.6%)--45 (88.2%)27 (90%)
Ultra-low anterior resection4 (3.7%)1 (2.9%)2 (2.9%)--4 (7.8%)3 (10%)
Abdominoperineal resection2 (1.8%)0 (0%)0 (0%)--2 (4%)0 (0%)
Emergency statusElective109 (100%)35 (100%)68 (97.1%)NS57 (100%)74 (97.4%)NS51 (100%)30 (100%)-
Semi-elective0 (0%)0 (0%)2 (2.9%)0 (0%)2 (2.6%)--
Laparoscopic approachTotally laparoscopic98 (89.9%)24 (68.6%)60 (85.7%)0.00956 (98.2%)71 (93.4%)NS41 (80.4%)14 (46.7%)0.002
Laparoscopy assisted11 (10.1%)11 (31.4%)10 (14.3%)1 (1.8%)5 (6.6%)10 (19.6%)16 (53.3%)
Preoperative optimizationBowel preparation107 (98.2%)30 (85.7%)54 (77.1%)< 0.00156 (98.2%)56 (73.7%)< 0.00150 (98%)29 (96.7%)NS
Antibiotic preparation105 (96.3%)33 (94.3%)68 (97.1%)NS54 (94.7%)73 (96.1%)NS50 (98%)29 (96.7%)NS
Tattoo36 (33%)2 (5.7%)13 (18.6%)0.00217 (29.8%)11 (14.5%)0.03219 (37.3%)4 (13.3%)0.021
Extraction sitePfannenstiel52 (47.7%)15 (42.9%)28 (40%)NS15 (26.3%)25 (32.9%)NS37 (72.5)18 (60%)NS
Subumbilical12 (11%)4 (11.4%)3 (4.3%)2 (3.5%)2 (2.6%)9 (17.6%)6 (20%)
Transumbilical45 (41.3%)16 (45.7%)39 (55.7%)40 (70.2%)49 (64.5%)5 (9.8%)6 (20%)
AnastomosisStapled85 (78.7%)24 (70.6%)50 (71.4%)NS34 (59.6%)46 (60.5%)NS50 (100%)29 (100%)NS
Handsewn23 (21.3%)10 (29.4%)20 (28.6%)23 (40.4%)30 (39.5%)0 (0%)0 (0%)
Intracorporeal57 (52.8%)16 (47.1%)39 (55.7%)NS18 (31.6%)32 (42.1%)NS38 (76%)24 (82.8%)NS
Extracorporeal51 (47.2%)18 (52.9%)31 (44.3%)39 (68.4%)44 (57.9%)12 (24%)5 (17.2%)
Protective stoma38 (34.9%)11 (31.4%)17 (24.3%)NS3 (5.3%)6 (7.9%)NS34 (66.7%)23 (76.7%)NS
Operation duration (min)180 (50)220 (60)180 (40)< 0.001160 (48)180 (40)0.003200 (50)220 (63)0.003
Open conversion13 (11.9%)2 (5.7%)5 (7.1%)NS4 (7%)2 (2.6%)NS8 (15.7%)6 (20%)NS
Transfusion5 (4.6%)0 (0%)3 (4.3%)NS3 (5.3%)1 (1.3%)NS1 (2%)3 (10%)NS
Tumor diameter (cm)3 (2.1)4 (2.4)3 (2)NS3 (1.5)3.5 (2)NS4 (2.4)3 (3)NS
Specimen length (cm)16.25 (7.25)22.5 (6.5)24 (8)< 0.00120.5 (8)23 (8.75)0.00114.25 (3.75)21 (6)< 0.001
Distal margin (cm)4 (3.5)7 (2)7 (5)< 0.0014 (2.5)7 (3.5)< 0.0014 (4.25)5 (4.5)NS
Lymph nodes15 (10)20 (19)21 (12)0.01615 (10)22 (13)0.00215 (10)12.5 (15)NS
Lymph node ratio0 (0)0 (0.8)0 (8)NS0 (4.5)0 (3.8)NS0 (0)0 (13.5)NS
Histological grade126 (24.5%)1 (2.9%)13 (19.7%)0.01310 (18.9%)10 (13.9%)0.00916 (31.4%)4 (13.3%)NS
260 (56.6%)27 (79.5%)48 (72.7%)31 (58.5%)58 (80.6%)27 (52.9%)19 (63.3%)
320 (18.9%)6 (17.6%)5 (7.6%)12 (22.6%)4 (5.6%)8 (15.7%)_7 (23.3%)
R status0105 (99.1%)33 (97.1%)66 (100%)NS53 (98.1%)71 (100%)NS51 (100%)29 (96.7%)NS
11 (0.9%)1 (2.9%)0 (0%)1 (1.9%)0 (0%)0 (0%)1 (3.3%)
Resection planeMesocoli/mesorectal91 (85.8%)31 (91.2%)61 (92.4%)NS43 (79.6%)65 (91.5%)NS47 (92.2%)28 (93.3%)NS
Intramesocolic/intramesorectal12 (11.3%)3 (8.8%)4 (6.1%)9 (16.7%)5 (7%)3 (5.9%)2 (6.7%)
Muscularis propria3 (2.8%)0 (0%)1 (1.5%)2 (3.7%)1 (1.4%)1 (2%)0 (0%)
Extramural vascular invasion30 (28.3%)7 (20.6%)17 (25.8%)NS13 (24.5%)20 (27.8%)NS16 (31.4%)5 (16.7%)NS
Perineural invasion13 (12.3%)4 (11.8%)4 (6.1%)NS7 (13.2%)6 (8.3%)NS6 (11.8%)2 (6.7%)NS
MucousFocal11 (10.4%)12 (35.3%)6 (9.1%)0.0066 (11.3%)14 (19.4%)NS4 (7.8%)5 (16.7%)NS
Diffuse9 (8.5%)3 (8.8%)8 (12.1%)7 (13.2%)8 (11.1%)2 (3.9%)3 (10%)
ComplicationsTotal28 (25.7%)9 (25.7%)12 (17.1%)NS15 (26.3%)18 (23.7%)NS12 (23.5%)4 (13.3%)NS
Wound infection5 (4.6%)2 (5.7%)2 (2.9%)NS1 (1.8%)4 (5.3%)NS4 (7.8%)0 (0%)NS
Wound dehiscence1 (0.9%)1 (2.9%)0 (0%)1 (1.8%)1 (1.3%)0 (0%)0 (0%)
Leak8 (7.3%)4 (11.4%)2 (2.9%)5 (8.8%)5 (6.6%)2 (3.9%)2 (6.7%)
Postoperative ileus7 (6.4%)1 (2.9%)3 (4.3%)4 (7%)4 (5.3%)3 (5.9%)0 (0%)
Urinary tract infection2 (1.8%)0 (0%)0 (0%)0 (0%)0 (0%)2 (3.9%)0 (0%)
Urinary retention1 (0.9%)0 (0%)1 (1.4%)0 (0%)1 (1.3%)1 (2%)0 (0%)
Bleeding1 (0.9%)0 (0%)2 (2.9%)0 (0%)1 (1.3%)1 (2%)1 (3.3%)
Pulmonary embolism1 (0.9%)1 (2.9%)0 (0%)1 (1.8%)1 (1.3%)0 (0%)0 (0%)
ARDS0 (0%)0 (0%)1 (1.4%)0 (0%)0 (0%)0 (0%)1 (3.3%)
Other3 (2.8%)0 (0%)1 (1.4%)3 (5.3%)1 (1.3%)0 (0%)0 (0%)
Relaparotomy5 (4.6%)3 (8.6%)3 (4.3%)NS2 (3.5%)6 (7.9%)NS2 (3.9%)1 (3.3%)NS
ICU6 (5.5%)1 (2.9%)1 (1.4%)NS4 (7%)1 (1.3%)NS2 (3.9%)1 (3.3%)NS
Mortality4 (3.7%)1 (2.9%)0 (0%)NS3 (5.3%)1 (1.3%)NS1 (2%)0 (0%)NS
Length of hospital stay (d)6 (2)6 (3)6 (2)NS6 (2)6 (2)NS6 (2)5 (1)NS
Follow-up (mo)2 (3.25)0.65 (0)6 (5)NS2 (3.3)6.8 (4.4)NS2 (3)0.27 (0)0.032